| Primary |
| Epilepsy |
55.7% |
| Drug Use For Unknown Indication |
9.1% |
| Convulsion |
7.1% |
| Product Used For Unknown Indication |
5.3% |
| Drug Exposure During Pregnancy |
4.7% |
| Parkinson's Disease |
3.6% |
| Partial Seizures |
2.4% |
| Migraine |
2.0% |
| Complex Partial Seizures |
1.5% |
| Grand Mal Convulsion |
1.5% |
| Hypertension |
1.2% |
| Encephalitis Herpes |
0.9% |
| Abnormal Behaviour |
0.8% |
| Convulsion Prophylaxis |
0.8% |
| Trigeminal Neuralgia |
0.8% |
| Headache |
0.6% |
| Pneumonia |
0.6% |
| Arthralgia |
0.5% |
| Arthritis |
0.5% |
| Depression |
0.5% |
|
| Therapeutic Response Unexpected With Drug Substitution |
9.4% |
| Weight Decreased |
9.4% |
| Rash |
7.7% |
| Convulsion |
6.6% |
| Drug Exposure During Pregnancy |
6.6% |
| Drug Interaction |
6.6% |
| Nephrolithiasis |
6.6% |
| Vomiting |
6.1% |
| Thrombocytopenia |
5.5% |
| Stevens-johnson Syndrome |
5.0% |
| Psychotic Disorder |
4.4% |
| Hypersensitivity |
3.3% |
| Product Substitution Issue |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Hypokalaemia |
2.8% |
| Neutropenia |
2.8% |
| Rash Generalised |
2.8% |
| Sleep Disorder |
2.8% |
| Urticaria |
2.8% |
| Aplastic Anaemia |
2.2% |
|
| Secondary |
| Epilepsy |
39.5% |
| Product Used For Unknown Indication |
13.1% |
| Drug Use For Unknown Indication |
9.6% |
| Convulsion |
8.8% |
| Partial Seizures |
3.6% |
| Schizophrenia |
2.8% |
| Colitis Ulcerative |
2.5% |
| Parkinson's Disease |
2.5% |
| Complex Partial Seizures |
2.4% |
| Hypertension |
2.0% |
| Encephalitis Herpes |
1.7% |
| Migraine |
1.7% |
| Drug Exposure During Pregnancy |
1.5% |
| Maternal Exposure Timing Unspecified |
1.4% |
| Asthma |
1.3% |
| Cerebrovascular Accident Prophylaxis |
1.3% |
| Trigeminal Neuralgia |
1.3% |
| Insomnia |
1.1% |
| Pain |
1.1% |
| Oesophageal Ulcer |
1.0% |
|
| Mental Impairment |
7.4% |
| Convulsion |
6.7% |
| Pancytopenia |
6.7% |
| Skin Injury |
6.7% |
| Vomiting |
6.7% |
| Completed Suicide |
5.9% |
| Status Epilepticus |
5.9% |
| Rash Generalised |
5.2% |
| Speech Disorder |
5.2% |
| Toxicity To Various Agents |
5.2% |
| Weight Decreased |
5.2% |
| Neutropenia |
4.4% |
| Suicide Attempt |
4.4% |
| Agitation |
3.7% |
| Mutism |
3.7% |
| Nystagmus |
3.7% |
| Suicidal Ideation |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Bradycardia |
3.0% |
| Brugada Syndrome |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.1% |
| Epilepsy |
15.7% |
| Convulsion |
12.8% |
| Pain |
10.7% |
| Drug Use For Unknown Indication |
6.4% |
| Depression |
5.2% |
| Multiple Sclerosis |
4.8% |
| Migraine |
4.3% |
| Infantile Spasms |
2.6% |
| Anxiety |
2.4% |
| Sleep Disorder |
1.9% |
| Hypertension |
1.6% |
| Insomnia |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Partial Seizures |
1.4% |
| Bipolar Disorder |
1.4% |
| Asthma |
1.2% |
| Fibromyalgia |
1.2% |
| Headache |
1.2% |
| Back Pain |
1.1% |
|
| Convulsion |
18.5% |
| Vomiting |
7.7% |
| Weight Increased |
7.5% |
| Weight Decreased |
7.2% |
| Type 2 Diabetes Mellitus |
6.7% |
| Pain |
6.4% |
| Vision Blurred |
6.4% |
| Drug Ineffective |
3.9% |
| Death |
3.3% |
| Pain In Extremity |
3.3% |
| Pyrexia |
3.3% |
| Somnolence |
3.3% |
| Pulmonary Embolism |
3.1% |
| Rash |
3.1% |
| Tremor |
3.1% |
| Urinary Tract Infection |
3.1% |
| Pharmaceutical Product Complaint |
2.6% |
| Visual Disturbance |
2.6% |
| Visual Impairment |
2.6% |
| Insomnia |
2.3% |
|
| Interacting |
| Epilepsy |
44.0% |
| Convulsion |
12.8% |
| Drug Use For Unknown Indication |
11.2% |
| Product Used For Unknown Indication |
9.6% |
| Type 1 Diabetes Mellitus |
3.2% |
| Anxiety |
1.6% |
| Crest Syndrome |
1.6% |
| Depression |
1.6% |
| Fibromyalgia |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hypertension |
1.6% |
| Impaired Gastric Emptying |
1.6% |
| Neuralgia |
1.6% |
| Pain |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Cystitis |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Pain In Extremity |
0.8% |
| Urinary Tract Infection |
0.8% |
|
| Drug Interaction |
15.6% |
| Paraesthesia |
13.3% |
| Vomiting |
13.3% |
| Psychotic Disorder |
8.9% |
| Lethargy |
6.7% |
| Mutism |
6.7% |
| Potentiating Drug Interaction |
4.4% |
| Pruritus |
4.4% |
| Pyrexia |
4.4% |
| Rash |
4.4% |
| Urticaria |
4.4% |
| Viral Infection |
4.4% |
| Crying |
2.2% |
| Dyskinesia |
2.2% |
| Neutropenia |
2.2% |
| Status Epilepticus |
2.2% |
|
